Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
Xtant Medical Holdings, Inc. (the "Company") held its 2024 annual meeting of stockholders (the "Annual Meeting") on July 23, 2024. As of the close of business on May 28, 2024, the record date for the Annual Meeting, there were 130,268,590 shares of the Company's common stock, par value $0.000001 per share (the "Common Stock"), outstanding and entitled to vote at the Annual Meeting. Each share of Common Stock was entitled to one vote. Stockholders holding an aggregate of 105,850,527 shares of Common Stock entitled to vote at the Annual Meeting, representing 81.25% of the outstanding shares of Common Stock as of the record date, and which constituted a quorum thereof, were present in person or represented by proxy at the Annual Meeting.
At the Annual Meeting, the Company's stockholders considered three proposals, each of which is described in more detail in the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on June 10, 2024 (the "2024 Proxy Statement").
The final results of such stockholder voting on each proposal brought before the Annual Meeting are set forth below:
Proposal One -
|
The six nominees proposed by the Company's Board of Directors were elected to serve as directors until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified by the following final voting results:
|
|
|
Votes For
|
|
|
Votes Withheld
|
|
|
Broker Non-Votes
|
|
John Bakewell
|
|
|
90,718,742
|
|
|
|
1,754,613
|
|
|
|
13,377,172
|
|
Jonn Beeson
|
|
|
90,660,062
|
|
|
|
1,813,293
|
|
|
|
13,377,172
|
|
Sean E. Browne
|
|
|
92,381,243
|
|
|
|
92,112
|
|
|
|
13,377,172
|
|
Robert McNamara
|
|
|
91,087,319
|
|
|
|
1,386,036
|
|
|
|
13,377,172
|
|
Lori Mitchell-Keller
|
|
|
91,087,511
|
|
|
|
1,385,844
|
|
|
|
13,377,172
|
|
Stavros Vizirgianakis
|
|
|
92,076,268
|
|
|
|
397,087
|
|
|
|
13,377,172
|
|
Proposal Two -
|
The Company's stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 by the following final voting results:
|
Votes For
|
|
|
Votes Against
|
|
|
Votes Abstained
|
|
|
Broker Non-Votes
|
|
|
105,696,806
|
|
|
|
15,794
|
|
|
|
137,927
|
|
|
|
0
|
|
Proposal Three -
|
The Company's stockholders approved, on an advisory basis, the compensation of the Company's executive officers named in the 2024 Proxy Statement by the following final voting results:
|
Votes For
|
|
|
Votes Against
|
|
|
Votes Abstained
|
|
|
Broker Non-Votes
|
|
|
90,807,497
|
|
|
|
1,388,264
|
|
|
|
277,594
|
|
|
|
13,377,172
|
|